tiprankstipranks
Grace Therapeutics (GRCE)
NASDAQ:GRCE
US Market
GRCE
Grace Therapeutics
RESEARCH TOOLSreports
Want to see GRCE full AI Analyst Report?

Grace Therapeutics (GRCE) Financial Statements

1,204 Followers

Grace Therapeutics Financial Overview

Grace Therapeutics's market cap is currently $36.83M. The company's EPS TTM is $-0.6357; its P/E ratio is -4.14; Grace Therapeutics is scheduled to report earnings on June 18, 2026, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -7.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -11.08M$ -23.75M$ -17.44M$ -70.54M$ -19.48M
EBITDA$ -11.07M$ -23.74M$ -15.37M$ -24.51M$ -19.17M
Net Income$ -9.49M$ -13.63M$ -17.44M$ -57.39M$ -12.27M
Balance Sheet
Cash & Short-Term Investments$ 16.98M$ 22.13M$ 23.00M$ 27.89M$ 43.66M
Total Assets$ 66.65M$ 71.99M$ 73.30M$ 79.12M$ 128.62M
Total Debt$ 0.00$ 0.00$ 0.00$ 485.00K$ 295.00K
Net Debt$ -16.98M$ -22.13M$ -23.00M$ -27.39M$ -30.04M
Total Liabilities$ 2.76M$ 5.38M$ 11.56M$ 11.17M$ 20.35M
Stockholders' Equity$ 63.90M$ 66.61M$ 61.74M$ 67.95M$ 108.27M
Cash Flow
Free Cash Flow$ -8.87M$ -14.90M$ -12.36M$ -15.93M$ -17.23M
Operating Cash Flow$ -8.87M$ -14.90M$ -12.33M$ -15.91M$ -17.23M
Investing Cash Flow$ 0.00$ 0.00$ 104.00K$ 13.15M$ -3.52M
Financing Cash Flow$ 3.71M$ 14.03M$ 7.36M$ 304.00K$ 0.00
Currency in USD

Grace Therapeutics Earnings and Revenue History

Income Statement >

Grace Therapeutics Debt to Assets

Balance Sheet >

Grace Therapeutics Cash Flow

Cash Flow >

Grace Therapeutics Forecast EPS vs Actual EPS

Earnings >